Tekturna (aliskiren) — High Blood Pressure Treatment
Links shared publicly online about this topic.
- 2,034total visits
Tekturna (aliskiren) — High Blood Pressure Treatment
View full resource at tekturna.com
Tags: Heart Disease, High Blood Pressure
Most Recently Shared on May 18, 2009 at 11:40 pm By:
DeMonaco: Media hype story repeated itself with Tekturna http://www.tekturna.com/index.jsp #ahcjnyc
Aliskiren-containing Medications: Drug Safety Comunication - New Warning and Contraindication
fda.gov — “Risk of renal impairment, hypotension, and hyperkalemia with concomitant use of aliskiren with angiotensin receptor blockers (ARBs) or angiotensin converting enzyme inhibitors (ACEIs) in patients with diabetes.” View full resource at fda.gov
Most Recently Shared on April 20, 2012 at 4:08 pm By:
#Safety ALERT: #Aliskiren-containing Meds: #pharm #endo #med #APRN - New Warning & Contraindication: http://t.co/0AgfKNXf
No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine - QualityPoint Technologies
qualitypointtech.net — “The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo®) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone has an insufficient effect. In an early benefit assessment pursuant to the” View full resource at qualitypointtech.net
Most Recently Shared on March 25, 2012 at 11:00 am By:
No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine: The fixed drug combination of aliskiren and aml... http://t.co/3t61fV6F
No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine
medicalnewstoday.com — “The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo®) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone h” View full resource at medicalnewstoday.com
Most Recently Shared on March 25, 2012 at 7:05 am By:
No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine http://t.co/LloszBoY #hypertension
Internal Medicine News - Comparison of the effects of aliskiren/valsartan in combination versus valsartan alone in patients with Stage 2 hypertension |3987966
mdlinx.com — “Internal Medicine Medical Article: Comparison of the effects of aliskiren/valsartan in combination versus valsartan alone in patients with Stage 2 hypertension” View full resource at mdlinx.com
Most Recently Shared on March 23, 2012 at 9:34 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Comparison of the effects of aliskiren/valsartan in combination versus valsartan alone in patients wit... http://t.co/euMu6AKz #medicine
Added Benefit of Fixed Combination Aliskiren/Amlodipine Is Not Proven - Drugs.com MedNews
drugs.com — “Drug manufacturer deviates from the appropriate comparator therapy specified by the G-BA The fixed drug combination of aliskiren and amlodipine (trade name Rasi” View full resource at drugs.com
Most Recently Shared on March 22, 2012 at 5:05 pm By:
Drugs and Devices OW OW Health
Added Benefit of Fixed Combination Aliskiren/Amlodipine Is Not Proven: Drug manufacturer deviates from the... http://t.co/plkmSGt5 #drug
Endocrinology News - Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus |3972811
mdlinx.com — “Endocrinology Medical Article: Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus” View full resource at mdlinx.com
Most Recently Shared on March 21, 2012 at 2:07 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus:... http://t.co/0TYEtMwP #endo
Comments of comparing Tekturna, Ramipril (study 6037093) - eHealthMe.com
ehealthme.com — “Is Ramipril 10 mg. an equal substitute for Tekturna 150 mg in terms of the dosage amount?” View full resource at ehealthme.com
Most Recently Shared on March 13, 2012 at 9:02 pm By:
Is Ramipril 10 mg. an equal substitute for Tekturna 150 mg in terms of the dosage amount? http://t.co/qTqfEUBJ
CardioSource - FDA Update
cardiosource.org — “CardioSource - FDA Update” View full resource at cardiosource.org
Most Recently Shared on March 2, 2012 at 4:03 pm By:
ACC Cardiology and Medical Society
#FDA update: Decision on Eliquis delayed http://t.co/Wv4cqsKB
ingentaconnect Aliskiren for the treatment of essential hypertension under real-...
ingentaconnect.com — “ingentaconnect Aliskiren for the treatment of essential hypertension under real-...” View full resource at ingentaconnect.com
Most Recently Shared on February 29, 2012 at 4:00 pm By:
Yvo Sijpkens MD Internist, Nephrologist, Physician, and Doctor
Aliskiren is used mainly in patients with more severe stages of hypertension and those with comorbidity (diabetes, CKD) http://t.co/I5Ao91J2
Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry - Zeymer - 2012 - International Journal of Clinical Practice - Wiley Online Library
onlinelibrary.wiley.com — “Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry - Zeymer - 2012 - International Journal of Clinical Practice - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on February 14, 2012 at 4:29 am By:
Aliskiren for the treatment of essential #hypertension under real-life practice conditions http://t.co/BM2j49R5 #cardiology
Risk Of Using Rasilez In Combination With Certain Blood Pressure-Lowering Drugs
medicalnewstoday.com — “Researchers at St. Michael's Hospital have published the first detailed figures showing the risk of using the prescription drug Rasilez in combination with certain other blood pressure-lowering me” View full resource at medicalnewstoday.com
Most Recently Shared on January 15, 2012 at 8:05 am By:
Risk Of Using Rasilez In Combination With Certain Blood Pressure-Lowering Drugs http://t.co/7E0x4VX5 #urology
PharmaLive: Novartis to Restructure US Business to Strengthen Competitive Position in Light of Loss of Diovan Patent and Announces Charge for Rasilez/Tekturna
pharmalive.com — “PharmaLive: Novartis to Restructure US Business to Strengthen Competitive Position in Light of Loss of Diovan Patent and Announces Charge for Rasilez/Tekturna” View full resource at pharmalive.com
Most Recently Shared on January 13, 2012 at 3:00 pm By:
PharmaLive Pharma and Health News
Novartis to Restructure US Business: http://t.co/7jAxEjgQ #pharma
Novartis to restructure US business to strengthen competitive position in light of loss of Diovan® patent and announces charge for Rasilez®/Tekturna® | Reuters
reuters.com — “Novartis International AG / Novartis to restructure US business to strengthen competitive position in light of loss of Diovan® patent and announces charge for Rasilez®/Tekturna® . Proce” View full resource at reuters.com
Most Recently Shared on January 13, 2012 at 7:48 am By:
blogaceutics Pharma and Health Communicator
Novartis to restructure US business to strengthen competitive position... [Reuters] http://t.co/JIF0sTuO
Monthly lists of letters for healthcare professionals on the safety of medicines : MHRA
mhra.gov.uk — “Monthly lists of letters for healthcare professionals on the safety of medicines : MHRA” View full resource at mhra.gov.uk
Most Recently Shared on January 5, 2012 at 2:25 pm By:
Warning letters about medicines (atomoxetine, escitalopram, domperidone, quetiapine and aliskiren) sent in December at http://t.co/gDYcxrA3
Riding High: Novartis And The Tekturna Chopper // Pharmalot
pharmalot.com — “Riding High: Novartis And The Tekturna Chopper // Pharmalot” View full resource at pharmalot.com
Most Recently Shared on December 21, 2011 at 1:59 pm By:
Riding High: Novartis and the Tekturna Chopper... see the motorcyle once used to plug the drug http://t.co/EcaU3fvS #pharma #motorcycle
Advertisement
